AFIB - Acutus Medical GAAP EPS of $0.41 beats by $1.12 revenue of $5M beats by $0.45M
2023-03-16 16:03:30 ET
- Acutus Medical press release ( NASDAQ: AFIB ): Q4 GAAP EPS of $0.41 beats by $1.12 .
- Revenue of $5M (+14.7% Y/Y) beats by $0.45M .
- Non-GAAP operating expenses were $13.9 million for the fourth quarter of 2022 compared with $21.4 million in the prior year.
-
Cash, cash equivalents, marketable securities and restricted cash were $76.2 million as of December 31, 2022.
-
2023 Outlook
-
The company expects full year 2023 revenue to be in a range from $18.0-$21.0 million.
For further details see:
Acutus Medical GAAP EPS of $0.41 beats by $1.12, revenue of $5M beats by $0.45M